Products found to contain undeclared medicines
|
| |
| United States: Public Notification: Lishou Fuling Jiaonang contains hidden drug ingredients |
| |
The United States Food and Drug Administration (FDA) announces to advise consumers not to purchase or use Lishou Fuling Jiaonang, a product promoted for weight loss. This product was identified during an examination of international mail shipments.
FDA laboratory analysis confirmed that Lishou Fuling Jiaonang contains sibutramine and N-desmethyl sibutramine. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. N-desmethyl sibutramine is a substance structurally similar to sibutramine. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or heart rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.
Please refer to the following website in FDA for details:
http://www.fda.gov/drugs/medication-health-fraud/public-notification-lishou-fuling-jiaonang-contains-hidden-drug-ingredients
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Thursday, June 27, 2019
Issued at HKT 15:30
|
| |
|
